Home - Products - Others - Other Targets - [D-Arg6,Asn10]-MCH (6-16) amide (human, mouse, rat)

[D-Arg6,Asn10]-MCH (6-16) amide (human, mouse, rat)

CAS No. 440635-61-0

[D-Arg6,Asn10]-MCH (6-16) amide (human, mouse, rat)( ——— )

Catalog No. M41383 CAS No. 440635-61-0

[D-Arg6,Asn10]-MCH (6-16) amide (human, mouse, rat)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [D-Arg6,Asn10]-MCH (6-16) amide (human, mouse, rat)
  • Note
    Research use only, not for human use.
  • Brief Description
    [D-Arg6,Asn10]-MCH (6-16) amide (human, mouse, rat)
  • Description
    [D-Arg6,Asn10]-MCH (6-16) amide (human, mouse, rat)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    440635-61-0
  • Formula Weight
    1449.8
  • Molecular Formula
    C60H100N22O14S3
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • C-telopeptide

    C-telopeptide, a cross-linked peptide of type I collagen, is released during bone resorption and has been correlated with bone mineral density (BMD).

  • α-Synuclein Binding?...

    α-Synuclein 4554W is an inhibitor of α-Synuclein (aSyn) aggregation with associated toxicity. α-Synuclein 4554W consists of GIVNGVKA sequences, previously identified through intracellular library screening. α-Synuclein 4554W reduces fibril formation of aSyn mutants assocaited with Parkinson’s disease.

  • Saikosaponin C

    Saikosaponin C efficiently inhibited LPS-induced apoptotic cell death via inhibition of caspase-3 activation and caspase-3-mediated-FAK degradation.